Analyst Research Report Snapshot

Title:

UPDATE: Glenmark announces a new Discovery and the Initiation of IND enabling studies of a novel monoclonal antibody targeting OX40

Price:

$5.00

Provider:

News Bites Pty Limited

Date:

05 Feb 2013

Pages:

16

Type:

AcrobatPDF

Companies referenced:

GLEN.NS

Available for Immediate Download
Summary:

Glenmark Pharmaceuticals Ltd. (NSE:GLENMARK), India's 9th largest pharmaceuticals company by market capitalisation, dipped Rs5.0 (or 1.0%) to close at Rs510.0. The volume was 0.7 times the average trading of 680,792 shares.

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.